AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 0.71 |
Market Cap | 6.61M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 77.53 |
PE Ratio (ttm) | 0.01 |
Forward PE | n/a |
Analyst | Buy |
Ask | 0.75 |
Volume | 178,577 |
Avg. Volume (20D) | 4,163,708 |
Open | 0.74 |
Previous Close | 0.73 |
Day's Range | 0.72 - 0.76 |
52-Week Range | 0.30 - 65.00 |
Beta | undefined |
About GRI
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sc...
Analyst Forecast
According to 2 analyst ratings, the average rating for GRI stock is "Buy." The 12-month stock price forecast is $11.5, which is an increase of 1453.21% from the latest price.
3 months ago · proactiveinvestors.co.uk
UK residential rent rises are slowing but Grainger says demand remains strongGrainger Plc (LSE:GRI) reported slower rental growth for recent months and said it expects further slowing in the coming year. The FTSE 250-listed private landlord, which owns around 12,000 homes, sa...